Topical Hypopigmenting Agents for Pigmentary Disorders and Their Mechanisms of Action

키워드

참고문헌 (50)

1. Gupta AK, "The treatment of melasma: a review of clinical trials", J Am Acad Dermatol, 55, pp.1048~1065 (2006)
2. Amer M, "Topical hydroquinone in the treatment of some hyperpigmentary disorders", Int J Dermatol, 37, pp.449~450 (1998)
3. Rendon MI, "Utilizing combination therapy to optimize melasma outcomes", J Drugs Dermatol, 3(5 Suppl), pp.S27~S34 (2004)
4. Bolognia JL, "Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoximine", Br J Dermatol, 133, pp.349~357 (1995)
5. Briganti S, "Chemical and instrumental approaches to treat hyperpigmentation", Pigment Cell Res, 16, pp.101~110 (2003)
6. 강희영, "The Role of Topical Retinoids in the Treatment of Pigmentary Disorders An Evidence-Based Review", AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 10(4), pp.251~260 (2009), ADIS INT LTD
7. Kim DS, "UVB-induced GM-CSF production is suppressed by dexamethasone in HaCaT cells", Photodermatol Photoimmunol Photomed, 17, pp.121~125 (2001)
8. Lee IW, "Effects of dexamethasone on endothelin-1 (ET-1) production by keratinocytes", Ann Dermatol, 13, pp.148~152 (2001)
9. Torok HM, "A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream", Am J Clin Dermatol, 7, pp.223~230 (2006)
10. Taylor SC, "Efficacy and safety of a new triple-combination agent for the treatment of facial melasma", Cutis, 72, pp.67~72 (2003)
11. Grimes P, "Community-based trial of a triple-combination agent for the treatment of facial melasma", Cutis, 77, pp.177~184 (2006)
12. Torok HM, "Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma", Cutis, 75, pp.57~62 (2005)
13. Hexsel D, "Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation", Br J Dermatol, 156(Suppl 1), pp.7~12 (2006)
14. Chan R, "A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma", Br J Dermatol, 159, pp.697~703 (2008)
15. Yasumoto K, "Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes", J Biol Chem, 272, pp.503~509 (1997)
16. Kim DS, "Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation", J Cell Sci, 116, pp.1699~1706 (2003)
17. Kim DS, "Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signalregulated kinase activation", Int J Biochem Cell Biol, 36, pp.1482~1491 (2004)
18. Kim DS, "Effects of lysophosphatidic acid on melanogenesis", Chem Phys Lipids, 127, pp.199~206 (2004)
19. Kim DS, "Ceramide inhibits cell proliferation through Akt", PKB inactivation and decreases melanin synthesis in Mel-Ab cells, 2001, pp.14, 110~115
20. Kim DS, "Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes", Cell Signal, 14, pp.779~785 (2002)
21. Mishima Y, "Selective aberration and pigment loss in melanosomes of malignant melanoma cells in vitro by glycosylation inhibitors: premelanosomes as glycoprotein", J Invest Dermatol, 81, pp.106~114 (1983)
22. Franchi J, "Depigmenting effects of calcium D-pantetheine-S-sulfonate on human melanocytes", Pigment Cell Res, 13, pp.165~171 (2000)
23. Sugai T., "Clinical effects of arbutin in patients with chloasma (in Japanese)", Hifu (Skin Res), 34, pp.522~529 (1992)
24. Chakraborty AK, "Effect of arbutin on melanogenic proteins in human melanocytes", Pigment Cell Res, 11, pp.206~212 (1998)
25. Moon KY, "Kojic acid, a potential inhibitor of NF-kappaB activation in transfectant human HaCaT and SCC-13 cells", Arch Pharm Res, 24, pp.307~311 (2001)
26. Kim DS, "Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis", Biol Pharm Bull, 28, pp.2216~2219 (2005)
27. 나정임, "Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial", JOURNAL OF DERMATOLOGY, 37, pp.311~315, BLACKWELL PUBLISHING
28. Fenoll LG, "Action mechanism of tyrosinase on meta- and para-hydroxylated monophenols", Biol Chem, 381, pp.313~320 (2000)
29. Ando H, "Linoleic acid and alpha-linolenic acid lightens ultraviolet-induced hyperpigmentation of the skin", Arch Dermatol Res, 290, pp.375~381 (1998)
30. Ando H, "Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis", J Lipid Res, 40, pp.1312~1316 (1999)
31. Ando H, "Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitinproteasome pathway", Biochem J, 394, pp.43~50 (2006)
32. Ando H, "Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function", J Biol Chem, 279, pp.15427~15433 (2004)
33. Martínez-Esparza M, "Transforming growth factor beta1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation", Int J Biochem Cell Biol, 33, pp.971~983 (2001)
34. Seiberg M, "Inhibition of melanosome transfer results in skin lightening", J Invest Dermatol, 115, pp.162~167 (2000)
35. Hakozaki T, "The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer", Dermatol, 147, pp.20~31 (2002)
36. Imokawa G, "The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis", Pigment Cell Res, 10, pp.218~228 (1997)
37. Kligman AM, "A new formula for depigmenting human skin", Arch Dermatol, 111, pp.40~48 (1975)
38. Yokota T, "The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation", Pigment Cell Res, 11, pp.355~361 (1998)
39. Karg E, "Hydrogen peroxide as an inducer of elevated tyrosinase level in melanoma cells", J Invest Dermatol, 100(2 Suppl), pp.209S~213S (1993)
40. Gukasyan GS, "Study of the kinetics of oxidation of monophenols by tyrosinase. The effect of reducers", Biochemistry, 67, pp.277~280 (2002)
41. Ros JR, "Effect of L-ascorbic acid on the monophenolase activity of tyrosinase", Biochem J, 295, pp.309~312 (1993)
42. Ichihashi M, "The inhibitory effect of DL-alpha-tocopheryl ferulate in lecithin on melanogenesis", Anticancer Res, 19, pp.3769~3774 (1999)
43. Nishiyama T, "Fused heterocyclic antioxidants: antioxidative activities of hydrocoumarins in a homogeneous solution", Biosci Biotechnol Biochem, 65, pp.1127~1133 (2001)
44. Yamamura T, "Antimelanogenic activity of hydrocoumarins in cultured normal human melanocytes by stimulating intracellular glutathione synthesis", Arch Dermatol Res, 294, pp.349~354 (2002)
45. Saliou C, "Antioxidants modulate acute solar ultraviolet radiation-induced NF-kappa-B activation in a human keratinocyte cell line", Free Radic Biol Med, 26, pp.174~183 (1999)
46. d'Ischia M, "Peroxidase as an alternative to tyrosinase in the oxidative polymerization of 5,6-dihydroxyindoles to melanin(s)", Biochim Biophys Acta, 1073, pp.423~430 (1991)
47. Kasraee B, "Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents", Dermatology, 205, pp.329~339 (2002)
48. Kasraee B, "Depigmentation of brown Guinea pig skin by topical application of methimazole", J Invest Dermatol, 118, pp.205~207 (2002)
49. 이동훈, "Terrein: A new melanogenesis inhibitor and its mechanism", Cellular and Molecular Life Sciences, 61(22), pp.2878~2885, Birkhauser Verlag
50. 김원곤, "Long-term suppression of tyrosinase by terrein via tyrosinase degradation and its decreased expression", EXPERIMENTAL DERMATOLOGY, 18, pp.562~566, BLACKWELL PUBLISHING

관련 논문AI추천